Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes.

Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens.

Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials.

As humans shape the environment through agriculture, industrialization, globalization, and technology, ecologies, including their microbes, evolve and adapt.

Raising occupational consciousness and critically questioning ahistorical and apolitical uses of "battle" is needed for responding to antimicrobial resistance.

This article summarizes how the AMA Code can be applied to antimicrobial resistance.

Antibiotics can be compared to other forms of “tragedy of the commons,” whereby a common good (effective treatment of infections) is jeopardized by individual consumption and lack of stewardship.

This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia.

Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people, especially in carceral settings.

Antimicrobial resistance is a looming pandemic, and poor health outcomes will not be borne equitably.